Literature DB >> 30949928

Posterior segment assessment in patients with obstructive sleep apnea syndrome.

Bekir Küçük1, Ender Sırakaya2, Şenol Delibaş3.   

Abstract

PURPOSE: The present study aimed to evaluate the lamina cribrosa thickness (LCT), lamina cribrosa depth (LCD), subfoveal and parafoveal choroidal thicknesses, peripapillary choroidal thickness (PCT), and retina nerve fiber layer (RNFL) thickness in patients with obstructive sleep apnea syndrome (OSAS) using spectral domain optical coherence tomography (SD-OCT).
METHODS: This single-center, case-control study included 45 OSAS patients and 43 age-and sex-matched healthy controls. Only the right eyes of the patients and controls were included. Each participant underwent a comprehensive ophthalmic assessment including slit lamp examination (biomicroscopy), stereoscopic fundus examination, and intraocular pressure (IOP) measurement. The SD-OCT measurements were also performed in both patients and controls.
RESULTS: The mean ages of the patients (females, 55.6%) and controls (females, 51.2%) were 50.09 ± 9.7 years and 50.30 ± 4.2 years, respectively. The groups were similar in terms of age and gender. Evaluation of the study parameters revealed that there were no significant differences between the OSAS patients and controls regarding IOP, RNFL thickness, subfoveal and parafoveal choroidal thicknesses, and PCT. A significant difference was found between the OSAS patients and controls regarding LCT but not regarding LCD. The mean LCT values were 213.38 ± 30.7 μm and 300.49 ± 42.6 μm for the OSAS patients and controls, respectively (p ˂ 0.001).
CONCLUSIONS: The results of the present study indicated that the lamina cribrosa was significantly thinner in the OSAS patients than in the controls. In our opinion, this finding should be supported by large-scale studies and the reason underlying the thinning of the lamina cribrosa in OSAS patients should be investigated physiopathologically.

Entities:  

Keywords:  Lamina cribrosa depth; Lamina cribrosa thickness; Obstructive sleep apnea syndrome; Retina; Spectral domain optical coherence tomography

Mesh:

Year:  2019        PMID: 30949928     DOI: 10.1007/s11325-019-01837-z

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.655


  31 in total

1.  Meta-Analysis of Association of Obstructive Sleep Apnea With Glaucoma.

Authors:  Shulin Liu; Yu Lin; Xin Liu
Journal:  J Glaucoma       Date:  2016-01       Impact factor: 2.503

2.  Reduced Retinal Vessel Density in Obstructive Sleep Apnea Syndrome Patients: An Optical Coherence Tomography Angiography Study.

Authors:  Jian Yu; Kuanlin Xiao; Jingjing Huang; Xinghuai Sun; Chunhui Jiang
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-07-01       Impact factor: 4.799

Review 3.  Obstructive sleep apnea-hypopnea syndrome (OSAHS) and glaucomatous optic neuropathy.

Authors:  Consuelo Pérez-Rico; Esperanza Gutiérrez-Díaz; Enrique Mencía-Gutiérrez; María Josefa Díaz-de-Atauri; Román Blanco
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-25       Impact factor: 3.117

4.  Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study.

Authors:  Sergio Tufik; Rogerio Santos-Silva; Jose Augusto Taddei; Lia Rita Azeredo Bittencourt
Journal:  Sleep Med       Date:  2010-04-01       Impact factor: 3.492

5.  Sleep-disordered breathing in multiple sclerosis.

Authors:  Tiffany J Braley; Benjamin M Segal; Ronald D Chervin
Journal:  Neurology       Date:  2012-08-15       Impact factor: 9.910

6.  Supine sleep and obstructive sleep apnea syndrome in Parkinson's disease.

Authors:  Valérie Cochen De Cock; Nicolas Benard-Serre; Valérie Driss; Manon Granier; Mahmoud Charif; Bertrand Carlander; Matthieu Desplan; Muriel Croisier Langenier; Didier Cugy; Sophie Bayard
Journal:  Sleep Med       Date:  2015-04-14       Impact factor: 3.492

7.  Deformation of the lamina cribrosa and anterior scleral canal wall in early experimental glaucoma.

Authors:  Anthony J Bellezza; Christopher J Rintalan; Hilary W Thompson; J Crawford Downs; Richard T Hart; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-02       Impact factor: 4.799

8.  Vascular impairment in Alzheimer's disease: the role of obstructive sleep apnea.

Authors:  Laura Buratti; Giovanna Viticchi; Lorenzo Falsetti; Claudia Cagnetti; Simona Luzzi; Marco Bartolini; Leandro Provinciali; Mauro Silvestrini
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

9.  Obstructive Sleep Apnea and Retinal Nerve Fiber Layer Thickness: A Meta-analysis.

Authors:  Xiao-Jing Zhao; Cheng-Cheng Yang; Jie-Chang Zhang; Hui Zheng; Ping-Ping Liu; Qin Li
Journal:  J Glaucoma       Date:  2016-04       Impact factor: 2.503

10.  Ocular blood flow in patients with obstructive sleep apnea syndrome (OSAS).

Authors:  Sarper Karakucuk; Sertan Goktas; Murat Aksu; Nuri Erdogan; Sevda Demirci; Ayse Oner; Hatice Arda; Koray Gumus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-04       Impact factor: 3.117

View more
  3 in total

1.  Ganglion cell layer thickening in patients suffering from Obstructive Sleep Apnea-Hypopnea syndrome with long Mean Apnea-Hypopnea Duration during sleep.

Authors:  Evangelia Chalkiadaki; Konstantinos Andreanos; Efthymios Karmiris; Chrysoula Florou; Xanthi Tsiafaki; Anastasia Amfilochiou; Ilias Georgalas; Chrysanthi Koutsandrea; Dimitrios Papaconstantinou
Journal:  Int Ophthalmol       Date:  2020-11-17       Impact factor: 2.031

2.  Assessment of the Effectiveness of Obstructive Sleep Apnea Treatment Using Optical Coherence Tomography to Evaluate Retinal Findings.

Authors:  Gloria Tejero-Garcés; Francisco J Ascaso; Paula Casas; Maria I Adiego; Peter Baptista; Carlos O'Connor-Reina; Eugenio Vicente; Guillermo Plaza
Journal:  J Clin Med       Date:  2022-02-03       Impact factor: 4.241

3.  Alterations in Parafoveal and Optic Disc Vessel Densities in Patients with Obstructive Sleep Apnea Syndrome.

Authors:  Turgay Ucak; Ethem Unver
Journal:  J Ophthalmol       Date:  2020-01-10       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.